Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock International Opportunities Portfolio

+ Add to Watchlist

BRECX:US

29.37 USD 0.01 0.03%

As of 09:29:30 ET on 02/26/2015.

Snapshot for BlackRock International Opportunities Portfolio (BRECX)

Year To Date: +5.31% 3-Month: +1.35% 3-Year: +5.67% 52-Week Range: 26.96 - 33.24
1-Month: +3.71% 1-Year: -7.88% 5-Year: +5.31% Beta vs MXWDU: 1.02

Mutual Fund Chart for BRECX

No chart data available.
  • BRECX:US 29.37
  • 1M
  • 1Y
Interactive BRECX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BRECX

BlackRock International Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective seeks long-term capital appreciation. The Fund invests at least 80% of net assets in equity securities issued by international companies. The Fund may invest up to 40% of its net assets in stocks of issuers in emerging market countries.

Inception Date: 09-26-1997 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / IAN JAMIESON
Web Site: www.blackrock.com

Fundamentals for BRECX

NAV (on 2015-02-26) 29.37
Assets (M) (on 2015-02-26) 1,199.54
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for BRECX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-12) 0.52
Dividend Yield (ttm) 14.76

Fees & Expenses for BRECX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.98
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.23

Top Fund Holdings for BRECX

Filing Date: 12/31/2014
Name Position Value % of Total
Novartis AG 545,800 50,619,390 3.926%
Baidu Inc 159,050 36,258,629 2.812%
Roche Holding AG 130,514 35,361,753 2.743%
Anheuser-Busch InBev NV 308,079 34,671,723 2.689%
Imperial Tobacco Group PLC 754,500 33,212,757 2.576%
AstraZeneca PLC 455,100 32,144,105 2.493%
Royal Dutch Shell PLC 938,700 31,286,162 2.427%
Teva Pharmaceutical Industries 479,000 27,547,290 2.137%
Liberty Global PLC 497,100 24,956,906 1.936%
Alibaba Group Holding Ltd 238,558 24,795,719 1.923%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil